Transplacental passage of etravirine and maraviroc in a multidrug-experienced HIV-infected woman failing on darunavir-based HAART in late pregnancy

被引：12
作者：
Calcagno, A. [1 ]
Trentini, L. [1 ]
Marinaro, L. [1 ]
Montrucchio, C. [1 ]
D'Avolio, A. [1 ]
Ghisetti, V. [2 ]
Di Perri, G. [1 ]
Bonora, S. [1 ]
机构：
[1] Univ Turin, Amedeo di Savoia Hosp, ASLTO2, Unit Infect Dis,Dept Med Sci, Turin, Italy
[2] Amedeo di Savoia Hosp, ASLTO2, Lab Virol & Microbiol, Turin, Italy
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2013年 / 68卷 / 08期
关键词：
pharmacokinetics; antiretrovirals; ws gIQ; virological failure; cord blood concentrations; PLASMA; DARUNAVIR/RITONAVIR; QUANTIFICATION; EFFICACY;
D O I：
10.1093/jac/dkt095
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1938 / 1939
页数：2
相关论文
共 9 条
[1]   HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients [J].
D'Avolio, Antonio ;
Siccardi, Marco ;
Sciandra, Mauro ;
Lorena, Baietto ;
Bonora, Stefano ;
Trentini, Laura ;
Di Perri, Giovanni .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 859 (02) :234-240
[2]   A Validated High-Performance Liquid Chromatography-Ultraviolet Method for Quantification of the CCR5 Inhibitor Maraviroc in Plasma of HIV-Infected Patients [J].
D'Avolio, Antonio ;
Simiele, Marco ;
Baietto, Lorena ;
Siccardi, Marco ;
Sciandra, Mauro ;
Patanella, Samantha ;
Bonora, Stefano ;
Di Perri, Giovanni .
THERAPEUTIC DRUG MONITORING, 2010, 32 (01) :86-92
[3]   Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens [J].
de Requena, Daniel Gonzalez ;
Bonora, Stefano ;
Vigano, Ottavia ;
Calcagno, Andrea ;
Cometto, Cristina ;
D'Avolio, Antonio ;
Baietto, Lorena ;
Ghisetti, Valeria ;
Magnani, Silvia ;
Ferramosca, Stefania ;
Vitiello, Paola ;
Galli, Massimo ;
Rusconi, Stefano ;
Di Perri, Giovanni .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (01) :192-200
[4]   Use of darunavir/ritonavir once daily in treatment-naive pregnant woman: pharmacokinetics, compartmental exposure, efficacy and safety [J].
Ivanovic, Jelena ;
Bellagamba, Rita ;
Nicastri, Emanuele ;
Signore, Fabrizio ;
Vallone, Cristina ;
Tempestilli, Massimo ;
Tommasi, Chiara ;
Mazzitelli, Luisa ;
Narciso, Pasquale .
AIDS, 2010, 24 (07) :1083-1084
[5]   Efficacy of darunavir despite low plasma trough levels during late pregnancy in an HIV-hepatitis C virus-infected patient [J].
Pacanowski, Jerome ;
Bollens, Diane ;
Poirier, Jean-Marie ;
Morand-Joubert, Laurence ;
Castaigne, Vanina ;
Girard, Pierre-Marie ;
Meyohas, Marie-Caroline .
AIDS, 2009, 23 (14) :1923-1924
[6]   Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1 [J].
Pinnetti, Carmelo ;
Tamburrini, Enrico ;
Ragazzoni, Enzo ;
De Luca, Andrea ;
Novarra, Pierluigi .
ANTIVIRAL THERAPY, 2010, 15 (01) :127-129
[7]   Transplacental passage of ritonavir-boosted darunavir in two pregnant women [J].
Ripamonti, D. ;
Cattaneo, D. ;
Cortinovis, M. ;
Maggiolo, F. ;
Suter, F. .
INTERNATIONAL JOURNAL OF STD & AIDS, 2009, 20 (03) :215-216
[8]   Clinical pharmacology of HIV protease inhibitors in pregnancy [J].
van der Lugt, Jasper ;
Colbers, Angela ;
Burger, David .
CURRENT OPINION IN HIV AND AIDS, 2008, 3 (06) :620-626
[9]   Total and unbound darunavir (DRV) pharmacokinetics (PK) in HIV-1-infected pregnant women [J].
Zorrilla, C. ;
Wright, R. ;
Osiyemi, O. ;
Yasin, S. ;
Baugh, B. ;
Brown, K. ;
Coate, B. ;
Verboven, P. ;
Hillewaert, V ;
Kakuda, T. .
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 :60-61
1